# Guangdong Zhongsheng Pharmaceutical

> Guangdong Zhongsheng Pharmaceutical is a VC fund backing Medical. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Dongguan, China
- Total investments: 3
- Last investment: Dec 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/guangdong-zhongsheng-pharmaceutical-co-ltd-/
- Website: http://www.zspcl.com

Guangdong Zhongsheng Pharmaceutical is a VC fund in Dongguan focused on Medical and Health Care. Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a high-tech pharmaceutical company dedicated to human health, and A-share listed company. The company was founded in 1979 with a registered capital of 814.461 million yuan and currently has 10 subsidiaries.

## Contacts

5 contacts available for Guangdong Zhongsheng Pharmaceutical. Shizune tracks 1 team members at Guangdong Zhongsheng Pharmaceutical. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/guangdong-zhongsheng-pharmaceutical?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Health Care | 1 | 33% |
| Life Science | 1 | 33% |
| Therapeutics | 1 | 33% |
| Biotechnology | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 2 | 67% |
| Series B | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 1 | 33% |
| South Korea | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Yonghong Chen | Chairman/President | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Raynovent | Raynovent is a science-driven innovative biotech company. | $53.6M | Series C | Dec 30, 2022 |  |
| QuadMedicine | Quadmedicine is a chance of healthy life,free from vaccine-preventable diseases. | $11.7M | Series C | May 11, 2022 |  |
| Raynovent | Raynovent is a science-driven innovative biotech company. | $39.7M | Series B | Dec 15, 2020 |  |

3 of 3 investments shown.

## Co-investors
- [EFung Capital](https://shizune.co/investors/profile/efung-capital) — VC Fund, 2 deals together
- [Bank of Communications](https://shizune.co/investors/profile/bank-of-communications) — VC Fund, 1 deal together
- [BioTrack Capital](https://shizune.co/investors/profile/biotrack-capital) — VC Fund, 1 deal together
- CITIC Medical Fund — VC Fund, 1 deal together
- [Eide Fund](https://shizune.co/investors/profile/eide-fund) — VC Fund, 1 deal together
- [Guangzhou Guoju Venture Capital](https://shizune.co/investors/profile/guangzhou-guoju-venture-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Guangdong Zhongsheng Pharmaceutical invest in?

Guangdong Zhongsheng Pharmaceutical invests primarily in Medical, Health Care and Life Science startups, most often at Series C and Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Guangdong Zhongsheng Pharmaceutical?

Public channels for Guangdong Zhongsheng Pharmaceutical include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Guangdong Zhongsheng Pharmaceutical?

The team at Guangdong Zhongsheng Pharmaceutical includes Yonghong Chen (Chairman/President). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co